Applied Clinical Trials-09-01-2021

Digitalization has revolutionized an industry once reliant on paper collection.

Improvements in data management and collaboration forge path to greater efficiency.

Using the promising-zone approach can salvage an underpowered trial.

Strong collaboration critical as trial development advances.

Capacity management and stability offer value for clients, their employees and FSP vendors.

Technology, talent and specialization add up to a plethora of industry M&As.

Insights from studies on advisory boards and participation burden.

Elizabeth Rickenbacher, PhD, Director of Strategy for 4G Clinical discusses changes in the IRT and RTSM solutions.

Slovenia brings EU health officials together for increased emphasis on repurposing.

A move back to in-house management of clinops could be on the horizon for sponsors.

Click the title above for a link to open the Applied Clinical Trials September 2021 issue in an interactive PDF format.

All eyes are watching closely to see how well Viatris and Biocon Biologics’ Semglee, approved by FDA on July 28, competes with Sanofi’s well-established, long-acting insulin analog, Lantus.